• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RBC Transfusion

Artificial Intelligence to Predict Perioperative RBC Transfusions

Accurately predicting the need for perioperative RBC transfusions reduces costs and conserves blood products while optimizing safety for patients. Since…

July 15, 2026

Tranexamic Acid Reduces RBC Transfusion for Adult Noncardiac Surgical Patients

Tranexamic acid is an inexpensive, antifibrinolytic drug that has been used since the 1960’s. While several randomized clinical trials and…

June 18, 2026

Influence of Transfusion Recipient and Donor Traits in Patients with Sickle Cell Disease

Many patients with sickle cell disease (SCD) receive chronic RBC transfusions to ensure non-sickled erythrocytes are in circulation. In 20-30%…

June 3, 2026

Pre-Hospital Resuscitation with Low-Titer Type O Whole Blood for Trauma Patients

Low-titer whole blood is increasingly used during prehospital transfusions for both military and civilian trauma patients because the logistics of…

May 26, 2026

Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

Few studies have explored the cost of typing and matching RBCs for transfusions. To understand the cost of the ABO…

May 14, 2026

Donor, Storage, and Processing Characteristics Associated with Platelet Transfusion Outcomes

Platelet transfusions are critical to many patients such as those with thrombocytopenia, bleeding patients, and patients at risk of bleeding….

May 5, 2026

Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

β-thalassemia and sickle cell disease (SCD) are the most common monogenic diseases worldwide. About 20% of these patients may be…

April 28, 2026

Jehovah’s Witness Governing Body Allows Autologous Transfusions

Jehovah’s Witnesses (JWs) are a Christian denomination founded in the late 19th century in the United States with a focus…

April 23, 2026

RBC Exchange Transfusion for Patients with Severe Babesiosis

Babesiosis is a tick-borne disease primarily transmitted by the intraerythrocytic protozoa Babesia microti in the U.S., which causes malaria-like symptoms…

April 14, 2026

Intravenous Iron More Effective than Oral to Treat Anemia in Postpartum Women

  Although the prevalence of postpartum anemia is common—as high as 50% in high-income countries and 80% in low- and…

April 1, 2026

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 23
  • Go to Next Page »

Primary Sidebar

Latest News

  • Artificial Intelligence to Predict Perioperative RBC Transfusions

  • Freeze-Dried Platelets Reduce Blood Brain Barrier Permeability and Intercranial Hemorrhage in Mice with Traumatic Brain Injury

  • α-Gal Sensitization in Group O Blood Recipients Linked to Severe Allergic Transfusion Reactions

  • WHO Reports on Strides and Inequalities in Whole Blood Donations

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley